Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2003
12/24/2003WO2003089593A3 Adjuvant enhanced immunotherapy
12/24/2003WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
12/24/2003WO2003075015A3 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
12/24/2003WO2003072558A3 Arylsulfone derivatives
12/24/2003WO2003072026A3 Method of reducing and treating uvb-induced immunosuppression
12/24/2003WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/24/2003WO2003070182A3 Sodium channel blockers
12/24/2003WO2003066806A3 Therapeutic use of aziridino compounds
12/24/2003WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene
12/24/2003WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists
12/24/2003WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
12/24/2003WO2003061703A9 Methods for treatment of multiple sclerosis with statins
12/24/2003WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
12/24/2003WO2003050251A3 Hematopoietic cells from human embryonic stem cells
12/24/2003WO2003048148A9 Statin-like compounds
12/24/2003WO2003040174A3 Substituted amino ketone compounds
12/24/2003WO2003003985A8 Polyvalent conjugate vaccine for cancer
12/24/2003WO2002096455A3 Use of polyclonal immunoglobulins
12/24/2003WO2002090542A3 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
12/24/2003WO2002074955A3 Oligonucleotides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof
12/24/2003WO2002046147A3 Perturbed membrane-binding compounds
12/24/2003WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications
12/24/2003CN1462755A Method for distilling active protein liquid of scorpion
12/24/2003CN1131712C Colostrinin and use thereof
12/24/2003CA2779633A1 Combination of azelastine and steroids
12/24/2003CA2779630A1 Combination of azelastine and steroids
12/24/2003CA2491846A1 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
12/24/2003CA2489367A1 Compounds, compositions, and methods
12/24/2003CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
12/24/2003CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
12/24/2003CA2489249A1 Carboxamides derivatives
12/24/2003CA2489004A1 Agonistic binding molecules to the human ox40 receptor
12/24/2003CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003CA2488026A1 Powdery respiratory tonic composition
12/24/2003CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003CA2486215A1 Mitotic kinesin inhibitors
12/24/2003CA2479309A1 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667334 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667316 Pharmaceutically active isoindoline derivatives
12/23/2003US6667312 Thioether substituted imidazoquinolines
12/23/2003US6667304 Affinity for melatonin receptors; sleep disorders; N-(2-(2-methoxy-6H-pyrido(2',3':4,5)pyrrolo(2,1-a)isoindol-11 -yl)ethyl)acetamide; N-(2-(3-methoxy-6,7,8,9-tetrahydropyrido (3,2-b)indolizin-5-yl) ethyl)acetamide
12/23/2003US6667300 Purinyl substituted quinazoline-4-one derivatives
12/23/2003US6667293 Of certain phosphorothioate antisense oligonucleotides used to treat pathogenic infections, cancer, and inherited conditions
12/23/2003US6667037 Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof
12/23/2003US6667025 Compositions and methods of using compositions with accelerated lymphocyte homing immunosuppressive properties
12/23/2003CA2149207C Compounds that inhibit t cell proliferation and methods using the same
12/18/2003WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003WO2003104467A1 Means and methods for the production of adenovirus vectors
12/18/2003WO2003104459A1 Fcyriia transgenic animal model for autoimmune disease
12/18/2003WO2003104456A1 Immunomodulation using altered dendritic cells
12/18/2003WO2003104407A2 T cell receptor cdr3 sequences and methods for detection
12/18/2003WO2003104260A2 Pharmaceutical formulation
12/18/2003WO2003104254A2 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders
12/18/2003WO2003104253A2 9-alpha-substituted estratrienes as selectively active estrogen
12/18/2003WO2003104235A1 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]pyrazines and decahydropyrazino[1,2-a]azepines
12/18/2003WO2003104230A1 Bicyclic pyrimidine derivatives
12/18/2003WO2003104229A1 Novel fused imidazole derivative
12/18/2003WO2003104226A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104225A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors
12/18/2003WO2003104219A1 Nf-kb inhibitors
12/18/2003WO2003104218A1 Nf-:b inhibitors
12/18/2003WO2003104213A1 Preparation process of biphenylcarboxylic acid amide derivatives
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104204A1 Pyridazine derivatives
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104198A1 Chemokine receptor antagonist
12/18/2003WO2003104197A1 Polymorphic form xvi of fexofenadine hydrochloride
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103713A1 Rapidly disintegrating tablet and process for producing the same
12/18/2003WO2003103709A2 Modulation of bone development
12/18/2003WO2003103708A1 BIOFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/18/2003WO2003103701A1 Compositions and methods for treating diabetes
12/18/2003WO2003103693A1 Use of a preparation produced from plant seedlings, enriched with electrolyte
12/18/2003WO2003103687A1 Liquid formulation of decitabine and use of the same
12/18/2003WO2003103671A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/18/2003WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
12/18/2003WO2003103665A1 Antiallergic
12/18/2003WO2003103663A2 Substituted pyrrolines as kinase inhibitors
12/18/2003WO2003103661A1 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/18/2003WO2003103658A1 Immunity-related protein kinase inhibitors
12/18/2003WO2003103656A1 O-substituted hydroxyaryl derivatives
12/18/2003WO2003103654A1 NF-kappaB ACTIVATION INHIBITORS
12/18/2003WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof
12/18/2003WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003WO2003103585A2 Methods of treating angiogenesis, tumor growth, and metastasis
12/18/2003WO2003103584A2 Ether substituted imidazopyridines
12/18/2003WO2003103575A2 Compounds, compositions, and methods
12/18/2003WO2003097052A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
12/18/2003WO2003087087A3 Heterocyclic compounds and their use as modulators of p38 map kinase
12/18/2003WO2003077881A3 Method for production of phytoalexins
12/18/2003WO2003074500A3 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
12/18/2003WO2003074068A3 Use of soluble fgl2 as an immunosuppressant
12/18/2003WO2003070701B1 Syntheses of quinazolinones
1 ... 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 ... 1172